BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 21, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

MDD's Oncology Extra

Oct. 16, 2013

Cleveland Clinic Medical Innovation Summit: Daschle: Those who defend status quo won't survive

Oct. 16, 2013
By Amanda Pedersen
Transformation has been the underlying theme of this year's Cleveland Clinic Medical Innovation Summit, beginning with the New Venture Healthcare Challenge on Monday (Medical Device Daily, Oct. 15, 2013) and continuing through former Sen. Tom Daschle's talk at dinner. Daschle told the roughly 1,500 Summit attendees that this country is on the brink of a historic transformation that, over the next decade, will change the healthcare landscape dramatically.
Read More

Amulyte takes Crowd Funding route to get device to market

Oct. 16, 2013
By Omar Ford
So just what can a med-tech start-up do to secure funding in a time where venture capital investors are extremely conservative with investment dollars? Why go to Crowd Investing of course.
Read More

Product Briefs

Oct. 15, 2013

People in the News

Oct. 15, 2013

MDD's Cardio Extra

Oct. 15, 2013

Cleveland Clinic Medical Innovation Summit: Start-ups take 'New Venture Healthcare Challenge'

Oct. 15, 2013
By Amanda Pedersen
Downtown Cleveland was abuzz with the feeling of rivalry Sunday night after the Detroit Lions beat the Cleveland Browns on the Browns' home turf. And on Monday morning at the brand new Global Center for Health Innovation, a friendlier competition was born as nearly a dozen early-stage companies positioned to solve some of healthcare's most pressing challenges competed in the New Venture Healthcare Challenge. The Challenge was part of the 11th annual Cleveland Clinic Medical Innovation Summit which runs through Wednesday.
Read More

Deals roundup: St. Jude completes $123.5M acquisition of Nanostim

Oct. 15, 2013
By Omar Ford

International report: CardioKinetix treats heart failure in China with Parachute device

Oct. 15, 2013

Washington roundup: Rapporteur recommends more EU device directives tightening

Oct. 15, 2013
By Mark McCarty
Previous 1 2 … 3415 3416 3417 3418 3419 3420 3421 3422 3423 … 10250 10251 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • UTRN gene involved in arthrogryposis, study finds

    BioWorld Science
    Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
  • Blue-gray dollar sign

    HMNC raises $50M series B to prep depression drugs for phase III

    BioWorld
    HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing